Cargando…
Resolving the dark side of therapy-driven cancer cell death
In this issue of JEM, Sulciner et al. (https://doi.org/10.1084/jem.20170681) provide evidence that therapy-induced cancer cell death can, paradoxically, stimulate and accelerate the growth of surviving malignant cells by fueling tumor-promoting inflammation. Resolvins, a class of lipid mediators, co...
Autores principales: | Bonavita, Eduardo, Pelly, Victoria S., Zelenay, Santiago |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748866/ https://www.ncbi.nlm.nih.gov/pubmed/29263217 http://dx.doi.org/10.1084/jem.20172044 |
Ejemplares similares
-
COX-2 upregulation by tumour cells post-chemotherapy fuels the immune evasive dark side of cancer inflammation
por: Bell, Charlotte R., et al.
Publicado: (2022) -
Src turns FHL1 to the dark side
por: Short, Ben
Publicado: (2018) -
Death, eaters, and dark marks
por: Collin, Matthew
Publicado: (2018) -
Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations
por: Bell, Charlotte R., et al.
Publicado: (2022) -
The dark side of radiotherapy-induced cell death in cancer
por: Alcalá, Sonia, et al.
Publicado: (2019)